It has also been described that metformin-induced cell cycle arrest is mediated by cyclin D1 inhibition and Rb dephosphorylation in prostate cancer cells (29) or by an AMPK-dependent mechanism requiring the downregulation of cyclin D1 and implication of p21 and p27 in breast cancer cells (54). Here, CCND1 is linked to prostate carcinoma.